Pfizer
Utility Patents
Last updated:
List of all Pfizer patents 177 in total
| Status | Patent |
|---|---|
Grant | Utility: 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Filling date: 13 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Antibodies specific for CD70 and their uses Filling date: 13 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Bifunctional cytotoxic agents containing the CTI pharmacophore Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Cysteine engineered antibody drug conjugates Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Anti-ROBO2 antibodies, compositions, methods and uses thereof Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Anti-AVB8 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Nitrile-containing antiviral compounds Filling date: 13 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Toll-like receptor agonists Filling date: 13 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]- -1'-carbonyl)-6-methoxypryridin-2-YL)benzoic acid Filling date: 13 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Site-specific integration Filling date: 13 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Chimeric antigen receptors targeting B-cell maturation antigen Filling date: 13 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Filling date: 13 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Crystalline form of lorlatinib free base hydrate Filling date: 13 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Antibodies specific for epidermal growth factor receptor variant III and their uses Filling date: 13 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Dosing regimen of avelumab for the treatment of cancer Filling date: 13 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: Chimeric antigen receptors targeting epidermal growth factor receptor variant III Filling date: 13 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Escherichia coli compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Tofacitinib oral sustained release dosage forms Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Combinations for treatment of NASH/NAFLD and related diseases Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Cyclin dependent kinase inhibitors Filling date: 13 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors Filling date: 13 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Compositions and methods relating to a mutant Clostridium difficile toxin Filling date: 13 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Anti-proliferative agents for treating PAH Filling date: 13 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Aminopyrimidinyl compounds Filling date: 13 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Dihydro-pyrrolo-pyridine derivatives Filling date: 13 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Vectors for expression of prostate-associated antigens Filling date: 13 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate Filling date: 13 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Cyclic substituted imidazo[4,5-c]quinoline derivatives Filling date: 13 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Filling date: 13 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Therapeutic antibodies and their uses Filling date: 13 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Immunogenic compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Engineered antibody constant regions for site-specific conjugation and methods and uses therefor Filling date: 13 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Azalactam compounds as HPK1 inhibitors Filling date: 13 Sep 2025 Issue date: 12 Oct 2021 |
Grant | Utility: Immunogenic compositions for use in pneumococcal vaccines Filling date: 13 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Glycoconjugation processes and compositions Filling date: 13 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Prostate-associated antigens and vaccine-based immunotherapy regimens Filling date: 13 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides Filling date: 13 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Filling date: 13 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Crystalline forms of lorlatinib maleate Filling date: 13 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Diacylglycerol acyl transferase 2 inhibitor Filling date: 13 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Antibodies to coagulation factor XIa and uses thereof Filling date: 13 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Solid dosage forms of palbociclib Filling date: 13 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: BCKDK inhibitors Filling date: 13 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: IL-15 variants and uses thereof Filling date: 13 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Cancer vaccines Filling date: 13 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody Avelumab Filling date: 13 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Diacylglycerol acyl transferase 2 inhibitors Filling date: 13 Sep 2025 Issue date: 15 Jun 2021 |
Showing 1 to 50 of 177 patents.